The present invention provides a sanitiser (10) for sanitising a user, having a plasma generator (20), for generating a plasma (22), a reservoir (30), for storing plasma (22) generated by the plasma generator 20 and having one or more inlets (32) connected to the plasma generator (20) and a first and second outlet (34), (36). One or more fluid movers (40), (42) cause movement of the plasma from the first and second outlets under the control of a controller (50) such as to cause the flow of plasma (22) out of one or other or both of said outlets (34), (36).

Methods for continuously inactivating virus during manufacture of a biological product are provided. The methods include steps of (1) combining (a) a composition including a biological product, and (b) a composition including a virus-inactivation reagent, to obtain (c) a treatment composition having a predetermined property for inactivation of a virus, (2) confirming that the treatment composition exhibits the predetermined property, (3) transferring the treatment composition to a treatment vessel that includes an inlet, an outlet, and a static mixer, the transferring occurring at the inlet, (4) incubating the treatment composition in the treatment vessel at a predetermined temperature while the treatment composition flows at a predetermined rate and contacts the static mixer, and (5) collecting the treatment composition from the treatment vessel at the outlet, wherein steps (1) to (5) are carried out continuously. Apparatuses and systems including such a treatment vessel are also provided.

Provided herein are methods for using 5-azacytidine in combination with one or more additional agents to treat diseases and disorders including acute myeloid or myelogenous leukemia (AML). Other disease and disorders those associated with abnormal cell proliferation, myelodysplastic syndromes (MDS), abnormal cell proliferation, hematologic disorders, and immune disorders, among others.

Provided herein are methods for using 5-azacytidine in combination with additional agents to treat diseases and disorders including AML.

A warming cabinet can include an enclosure, a heater for heating the enclosure, and a package disposed within the enclosure. A method of disinfecting skin can include removing a package from a storage environment having an above-ambient temperature, removing a wipe from the package, and applying the wipe to skin.

A hand sanitizing station apparatus for convenient zero contact sanitization includes a basin coupled to a housing. A misting tip is coupled to the basin through a tip aperture. A head of the misting tip has a release aperture to create a mist. A feeder tube is coupled to the misting tip and a tank is coupled to the feeder tube and contains pressurized hand sanitizer. A release valve is coupled to the feeder tube between the tank and the misting tip. A motion sensor is coupled to the basin and is in operational communication with the release valve to allow flow of the pressurized hand sanitizer through to the release aperture of the misting tip when a user's hands are placed within the basin.

The invention provides methods of using environmentally compatible detergents in the field of recombinant protein manufacturing for inactivating viruses in a product feedstream in the manufacturing process of proteins intended for administration to a patient, such as therapeutic or diagnostic proteins. The invention further provides methods wherein the environmentally compatible detergent used in the present invention maintains product quality of the therapeutic or diagnostic protein whilst effectively inactivating viruses.

One aspect of the present invention relates to a waste liquid treatment composition for treating a waste liquid containing a body fluid to separate the waste liquid into a supernatant and an aggregate in a container. The waste liquid treatment composition comprises: a solid flocculant having at least one group selected from the group consisting of an OH group, an NH group, and an FH group; and a solid compound having at least one group selected from the group consisting of an OH group, an NH group, and an FH group.

The present invention provides a sanitiser 10 for sanitising a user, having a plasma generator 20, for generating a plasma 22, a reservoir 30, for storing plasma 22 generated by the plasma generator 20 and having one or more inlets 32 connected to the plasma generator 20 and a first and second outlet 34, 36. One or more fluid movers 40, 42 cause movement of the plasma 2 from the first and second outlets under the control of a controller 50 such as to cause the flow of plasma 22 out of one or other or both of said outlets 34, 36.

The present invention discloses a plasma aerosol device, comprising a gas tunnel, a dielectric barrier discharge module, and a liquid tunnel. The invention uses a mechanism similar to a dielectric barrier discharge (DBD) electrode system, thus to enable generating a plasma active water mist which riches in free radicals such as reactive nitrogen species (RNS) and reactive oxygen species (ROS). Therefore, this invention is able to be used in medical, sterilization, agriculture and preservation industries.